Novo Nordisk is to cut costs as the Wegovy-maker battles competition from rival Eli Lilly and copycat versions of its obesity ...

Second-quarter sales of the blockbuster drug soared 67% on year, despite millions of U.S. patients using generic unbranded ...

Wegovy-maker Novo Nordisk said on Wednesday it will sharpen its commercial focus and reduce costs, after a major profit ...

Sales of Novo Nordisk's blockbuster Wegovy obesity drug rose 67% in the second quarter despite continued competition from ...

Hims’ second-quarter revenue fell 7% from a quarter ago. The decline goes beyond weakness in its GLP-1 weight-loss business.

When it comes to weight loss, there are a number of tried and true lifestyle changes you can make to help you along the way.

Semaglutide--which is marketed as Wegovy for weight-loss and Ozempic for diabetes--had been in short supply as the company raced to increase production and meet surging demand. But the drug came off ...

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

Glencore Earnings Fall on Lower Coal Prices, Copper Production Challenges The commodities giant said the results reflect lower coal prices and a drop in copper production following operational ...

People using weight loss medication have been told it's not a "quick fix" with many at risk of regaining their lost weight.

The number of people taking weight-loss injections is exploding. With more and more men going “on the needle”, here’s what ...

Muscle and strength loss in human aging, also known as sarcopenia, can result in trouble with balance and walking, according ...